• VertiFlex (San Clemente, California) has named Catherine Kusnick, MD, as VP of medical and clinical affairs and reported the continued progress of the ISISS clinical trial investigating the Superion Interspinous Spacer for the treatment of spinal stenosis. Previously, Kusnick headed the clinical affairs departments at Interventional Spine, 3F Therapeutics and SenoRx. VertiFlex also said that Michel Hughes was named VP of international sales. Hughes was VP of Western U.S. sales and international for Biomet. VertiFlex makes percutaneous, minimally invasive motion-preservation technologies for disorders of the spine.

No Comments